Cresilon, Inc.

Cresilon, Inc. is a pioneering medical device company based in Brooklyn, New York, dedicated to developing innovative hemostatic technologies that enhance wound care and improve medical treatment standards. The company's flagship product, VETIGEL®, is a groundbreaking hemostatic gel specifically formulated for veterinary use, designed to control bleeding in animals by achieving hemostasis in seconds. Cresilon's mission is clear: to save lives through reliable and effective bleeding control solutions that can be utilized effortlessly at the point of care.

Cresilon's unique approach leverages plant-based polymers to support the natural clotting process, setting it apart from traditional methods that require manual pressure or are less efficient. This revolutionary gel not only aims to provide immediate relief in trauma and surgical scenarios for animals but also targets future applications in human trauma and surgical care. The company’s commitment to innovation is underscored by its ongoing research and development efforts, focusing on expanding its product lines to meet the needs of both veterinary and human medicine.